Jacobs Levy Equity Management, Inc Astria Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.42 - $8.06 $39,360 - $71,774	-8,905 Reduced 5.51%	152,732 $1.17 Million
Q3 2023 Nov 16, 2023	BUY	$6.89 - $9.86 $219,487 - $314,100	31,856 Added 24.55%	161,637 $1.21 Million
Q2 2023 Aug 14, 2023	BUY	$8.33 - $13.72 $992,169 - $1.63 Million	119,108 Added 1115.97%	129,781 $1.08 Million
Q1 2023 May 15, 2023	BUY	$11.2 - $15.79 $119,537 - $168,526	10,673 New	10,673 $141,000

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $135M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.